Artificial Intelligence in Healthcare Diagnosis Market Report 2026

The artificial intelligence in healthcare diagnosis market size has grown exponentially in recent years. It will grow from $33.03 billion in 2025 to $48.39 billion in 2026 at a compound annual growth rate (CAGR) of 46.5%. The growth in the historic period can be attributed to rising diagnostic workloads, shortage of medical specialists, growth of electronic health records, need for diagnostic accuracy, expansion of digital healthcare systems.

The artificial intelligence in healthcare diagnosis market size is expected to see exponential growth in the next few years. It will grow to $226.56 billion in 2030 at a compound annual growth rate (CAGR) of 47.1%. The growth in the forecast period can be attributed to increasing adoption of AI diagnostics, growth of precision medicine, demand for faster diagnosis, integration of AI with hospital systems, regulatory approvals for AI tools. Major trends in the forecast period include ai-assisted clinical diagnosis, predictive diagnostic analytics, automated medical data interpretation, integrated diagnostic decision support, multi-modality diagnostic platforms.

The increasing prevalence of chronic diseases is anticipated to drive the expansion of the artificial intelligence in healthcare diagnosis market in the coming years. Chronic diseases are long-term medical conditions that typically develop gradually and often persist over extended periods. Artificial intelligence (AI) in healthcare diagnosis has the potential to substantially influence the management and identification of chronic diseases, as it supports cost reduction and more efficient use of resources. It enables healthcare professionals to make more informed decisions, identify at-risk patients, and deliver more personalised care. For instance, in April 2025, according to the International Diabetes Federation (IDF), a Belgium-based non-profit organization, 589 million people were living with diabetes in 2024, and this figure is projected to rise to 853 million by 2050. Therefore, the growing burden of chronic diseases is fueling the growth of the artificial intelligence in healthcare diagnosis market.

Major players in the artificial intelligence in the healthcare diagnosis market are directing their efforts toward the development of innovative solutions, with a focus on AI-powered disease detection. This involves leveraging artificial intelligence technologies to analyze medical data, including images, patient records, and diagnostic tests, for the identification and detection of various diseases or health conditions. For example, in May 2023, Aegis Ventures LLC, a next-generation venture studio based in the US, partnered with Northwell Holdings, a US-based medical technology company, to introduce ‘Optain’. Utilizing images of the eye captured with a simple, portable retinal camera, Optain's AI not only screens for eye-related conditions but also identifies 140 diseases throughout the body. The goal is to detect these diseases at the earliest stage when they are most treatable.

In April 2025, HEALWELL AI, a Canada-based healthcare artificial intelligence company, acquired Orion Health Holdings Limited for approximately NZD 175 million (USD 104 million), along with an additional earn-out of up to NZD 25 million. Through this acquisition, HEALWELL artificial intelligence (AI) seeks to strengthen its AI-driven clinical decision-support capabilities by incorporating Orion Health’s interoperability and data-management technologies across enterprise healthcare systems. Orion Health Holdings Limited is a New Zealand-based global healthcare intelligence platform that serves public-sector healthcare organizations.

Major companies operating in the artificial intelligence in healthcare diagnosis market are Johnson and Johnson Private Limited; Intel Corporation; International Business Machines Corporation; Medtronic; Nvidia Corporation; Siemens Healthcare GmbH; Koninklijke Philips N.V.; GE Healthcare; Agfa-Gevaert Group; Google Deep Mind; Babylon Health; HeartFlow Inc.; Corti HQ; Aidoc; Aidoc Medical Ltd.; Imagen Technologies; AliveCor Inc.; Digital Diagnostics Inc.; Enlitic Inc.; NovaSignal Corp.; Cleerly Inc.; Butterfly Network Inc.; IBM Watson Health; Arterys Inc.; Zebra Medical Vision Inc.; Vuno Inc.; Riverain Technologies; CloudMedX Inc.; Neural Analytics Inc.

North America was the largest region in the artificial intelligence in healthcare diagnosis market in 2025. The regions covered in the artificial intelligence in healthcare diagnosis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the artificial intelligence in healthcare diagnosis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs have influenced the artificial intelligence in healthcare diagnosis market by increasing costs of imported diagnostic hardware, imaging devices, and computing infrastructure. These impacts are more pronounced for hospitals and diagnostic imaging centers using advanced ai-powered systems. Regions such as asia pacific and europe face supply chain challenges due to dependence on imported components. Higher costs have accelerated adoption of software-based diagnostic solutions. This shift has strengthened demand for cloud-enabled and scalable AI diagnostic platforms.

The artificial intelligence in healthcare diagnosis market research report is one of a series of new reports that provides artificial intelligence in healthcare diagnosis market statistics, including artificial intelligence in healthcare diagnosis industry global market size, regional shares, competitors with a artificial intelligence in healthcare diagnosis market share, detailed artificial intelligence in healthcare diagnosis market segments, market trends and opportunities, and any further data you may need to thrive in the artificial intelligence in healthcare diagnosis industry. This artificial intelligence in healthcare diagnosis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Artificial intelligence (AI) in healthcare diagnosis involves the application of AI techniques, such as machine learning and deep learning algorithms, for the purpose of diagnosing medical conditions. The utilization of AI allows for the rapid evaluation of data, encompassing clinical trials, medical records, and genetic information, providing medical practitioners with a quicker diagnosis compared to traditional human methods.

The primary components incorporated in artificial intelligence in healthcare diagnosis consist of software, services, and hardware. Software is a compilation of programs, data, and instructions designed to execute specific tasks on a computer or electronic device. These components are utilized across various medical diagnoses, including cardiology, oncology, pathology, radiology, chest and lung, neurology, and others. The modalities involved comprise MRI (magnetic resonance imaging), CT (computed tomography), X-ray, and ultrasound, catering to applications in both in vivo and in vitro diagnostics. The end-users benefiting from these AI applications include hospitals, diagnostic imaging centers, diagnostic laboratories, and others.

The artificial intelligence (AI) in healthcare diagnosis market consists of revenues earned by entities by providing medical imaging analysis, genetic analysis, clinical decision support, risk prediction and stratification. The market value includes the value of related goods sold by the service provider or included within the service offering. The artificial Intelligence (AI) in the healthcare diagnosis market also includes sales of surgical robots and visual tools which are used in providing AI in healthcare diagnosis services. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.